Phase II national clinical trial of prophylactic irradiation to the contralateral breast for BRCA mutation carriers treated for early breast cancer (EBC).Ella Evron, Benjamin W. Corn, Hadassah Goldberg et al.|Journal of Clinical Oncology|2018Cited by 3